News

ACN Newswire – Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services Targeting New Diagnostic Tests and Improved Drug Development

PERTH, W. AUSTRALIA, Feb 12, 2018 – (ACN Newswire) – MedTech pioneer Proteomics International (PILL; ASX: PIQ) has entered into a strategic alliance with CPR Pharma Services (CPR), targeting the high growth area of clinical trials and related research, with an offer to acquire 10% of CPR’s share capital through the issue of 4 million PIQ shares.

Article: Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services Targeting New Diagnostic Tests and Improved Drug Development

Subscribe
  • This field is for validation purposes and should be left unchanged.